# Archipel Capital

> Archipel Capital is a VC fund in Buffalo backing Genetics, Health Care and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Buffalo, United States
- Total investments: 1
- Last investment: Jan 2015
- Lead investor: 0%
- Last updated: Aug 2026

Archipel Capital is a venture capital firm specialized in in growth capital investments.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Genetics | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Lineagen | Lineagen is a provider of diagnostic and healthcare services focused on complex diseases for which an individual's genetic profiles contribute strongly to their susceptibility. Lineagen is committed to improving outcomes for those affected by autism and other complex diseases, for which effective early diagnosis and intervention can have asignificant positive impact. The company's comprehensive genetic testing and support/counseling service are initially designed to enable early evaluation of children at risk for disorders of childhood development, including autism spectrum disorders (ASDs). Founded in 2002, Lineagen's commercial strategy represents the culmination of significant proprietary research into genetic causes and diagnostic pathways of key complex diseases, including autism, MS, and COPD. One of the company's core research competitive advantages is its access through the University of Utah to the Utah Population Database, an unmatched biomarker discovery research platform that has been used to help the University identify more disease-related genes than any other institution in the world. | $12.2M | Series C | Jan 26, 2015 |  |

1 of 1 investments shown.

## Co-investors
- [HealthQuest Capital](https://shizune.co/investors/profile/heathquest-capital-2) — VC Fund, 1 deal together
- [Kickstart Ventures](https://shizune.co/investors/profile/kickstart-ventures) — VC Fund, 1 deal together
- [Mesa Verde Venture Partners](https://shizune.co/investors/profile/mesa-verde-venture-partners) — VC Fund, 1 deal together
- [Mountain Group Capital](https://shizune.co/investors/profile/mountain-group-capital) — VC Fund, 1 deal together
- [Petra Capital Partners](https://shizune.co/investors/profile/petra-capital-partners) — VC Fund, 1 deal together
- [PrairieGold Venture Partners](https://shizune.co/investors/profile/prairiegold-venture-partners) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Archipel Capital invest in?

Archipel Capital invests primarily in Genetics, Health Care and Biotechnology startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Archipel Capital last invest?

The most recent investment recorded for Archipel Capital closed in Jan 2015. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co